Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in ...
Leadership
Bruce D. Steel C.F.A.Founder
Co-Founder, CEO & Director
Stephen Connelly Ph.D.
Chief Scientific Officer & President
Christine Zedelmayer M.B.A., P.M.P.
Senior VP & COO
Penny Tom CPA
Senior VP of Finance & Principal Accounting Officer
Michael Moore
Vice President of Investor Relations & Corporate Communications
